Quarterly Financial Data (Unaudited)

12 Months Ended

Dec. 31, 2019

Note 29. Quarterly Financial Data (Unaudited)

The following table sets forth a summary of the Company’s quarterly results of operations for the years ended December 31, 2019 and 2018.

	For the Three Months Ended
2019	March 31,		June 30,		September 30,		December 31,			Full Year (1),
Net sales	$	1,376	$	1,408	$	1,390	$	1,353		$	5,526
Cost of goods sold		1,080		1,085		1,096		1,203			4,463
Income (loss) before income taxes		107		133		91		(454	)		(124	)
Net income (loss)		94		96		76		(317	)		(52	)
Net income (loss) attributable to Chemours		94		96		76		(317	)		(52	)
Basic earnings (loss) per share of common stock		0.56		0.58		0.46		(1.94	)		(0.32	)
Diluted earnings (loss) per share of common stock		0.55		0.57		0.46		(1.94	)		(0.32	)

	For the Three Months Ended
2018	March 31,		June 30,		September 30,		December 31,		Full Year (1),
Net sales	$	1,730	$	1,816	$	1,628	$	1,464	$	6,638
Cost of goods sold		1,193		1,259		1,151		1,064		4,667
Income before income taxes		381		323		269		182		1,155
Net income		297		282		275		142		996
Net income attributable to Chemours		297		281		275		142		995
Basic earnings per share of common stock		1.63		1.58		1.56		0.83		5.62
Diluted earnings per share of common stock		1.58		1.53		1.51		0.81		5.45

(1)

Individual quarters may not sum to full year amounts due to rounding.